Lemaitre Vascular Inc. Revenue 2020–2025
Lemaitre Vascular Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lemaitre Vascular Inc. revenue for the quarter ending March 31, 2026 was 66.6 M, a 11.16% increase year-over-year.
- Lemaitre Vascular Inc. revenue for the twelve months ending March 31, 2026 was 256.3 M.
- Lemaitre Vascular Inc. annual revenue for 2025 was 249.6 M, a 13.53% increase from 2024.
- Lemaitre Vascular Inc. annual revenue for 2024 was 219.9 M, a 13.63% increase from 2023.
- Lemaitre Vascular Inc. annual revenue for 2023 was 193.5 M, a 19.69% increase from 2022.
- Lemaitre Vascular Inc. annual revenue for 2022 was 161.7 M.
Lemaitre Vascular Inc. (LMAT) — Frequently Asked Questions
Lemaitre Vascular Inc. (LMAT) is a publicly traded US company. It has a market capitalization of $2.07B. In fiscal 2025 it reported revenue of $250M and net income of $58M. Explore LMAT's stock price, financial statements, earnings history, margins and key ratios below.
What is Lemaitre Vascular Inc.'s market cap?
Lemaitre Vascular Inc. (LMAT) has a market capitalization of $2.07B.
What is the LMAT stock price?
LMAT trades at $91.56 (-0.84% on the day).
How much revenue does Lemaitre Vascular Inc. make?
Lemaitre Vascular Inc. reported revenue of $250M in fiscal 2025.
Is LMAT profitable?
In fiscal 2025, Lemaitre Vascular Inc. reported net income of $58M.
What is LMAT's P/E ratio?
Based on diluted EPS, LMAT has a price-to-earnings (P/E) ratio of about 36.3.